and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Want to know more about the concerns shaping the world? Our talks and Q&As with leading writers, thinkers and activists have it covered
The paradox of secularism and the contemporary value of progress is that the origins of both lie in the seedbed of a religious past
Puzzle: can you win like P ConNers?
Puzzle: what did the Dutch master miss?
Staff and students call for review into practices following FT investigation
Documents show privileged access to the Boat Race and continued acceptance of donations
Works on show at Weston Library include a daguerreotype where Queen Victoria scratched out her face
Millions of pounds are being invested to turn scientific research into global companies. But some founders say they have to give up too much equity
Sunak offers renewed backing for plan to develop ‘UK Silicon Valley’ after it was shelved by Johnson government
Results of UK study show drug cuts symptom duration by about 4 days but does not reduce deaths
Before she steps down this month, the vice-chancellor of Oxford university talks about cancel culture, state schools and why universities should not be businesses
Christ Church racked up a £6.6mn bill for legal and PR fees in a dispute with Martyn Percy
Investors are crowding in on the promise of ‘unlimited clean energy’
Setback for a method hoped to provide better protection against virus transmission
Technology used to develop Covid vaccines may help in the fight against other diseases
Are the sceptics too sceptical?
Having helped create the AstraZeneca Covid-19 drug, the Oxford scientist has another urgent goal, to eliminate malaria through vaccination
Reputation for long-term stability under pressure amid concerns over chief executive’s management style
The industry has yet to demonstrate any real utility, despite the fanfare, billions of VC dollars and three Spacs
Long-term effects are generally less in children, although infection doubles risk of epilepsy
Investors warn that lack of availability is driving some companies to US cities
Oxford Science Enterprises wants to step up funding of companies derived from academic research
Could the prime minister’s fall be a turning point for Britain?
Failure in sport is clear-cut and gets punished, unlike in government
Christ Church issues statement as dispute with Martyn Percy continues despite £1.2mn settlement